These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20232002)

  • 1. [Health technology assessment: research methodology].
    Nita ME; Secoli SR; Nobre M; Ono-Nita SK
    Arq Gastroenterol; 2009; 46(4):252-5. PubMed ID: 20232002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health technology assessment: II. Cost effectiveness analysis].
    Secoli SR; Nita ME; Ono-Nita SK; Nobre M
    Arq Gastroenterol; 2010; 47(4):329-33. PubMed ID: 21225140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why rankings of biomedical image analysis competitions should be interpreted with care.
    Maier-Hein L; Eisenmann M; Reinke A; Onogur S; Stankovic M; Scholz P; Arbel T; Bogunovic H; Bradley AP; Carass A; Feldmann C; Frangi AF; Full PM; van Ginneken B; Hanbury A; Honauer K; Kozubek M; Landman BA; März K; Maier O; Maier-Hein K; Menze BH; Müller H; Neher PF; Niessen W; Rajpoot N; Sharp GC; Sirinukunwattana K; Speidel S; Stock C; Stoyanov D; Taha AA; van der Sommen F; Wang CW; Weber MA; Zheng G; Jannin P; Kopp-Schneider A
    Nat Commun; 2018 Dec; 9(1):5217. PubMed ID: 30523263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
    Pereira VC; Barreto JOM; Neves FADR
    PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NICE Health Technology Appraisal Programme.
    Burchell M; Ruiz F; Barnett D
    Ann R Coll Surg Engl; 2005 Jul; 87(4):283-4. PubMed ID: 16884603
    [No Abstract]   [Full Text] [Related]  

  • 6. [Health technology assessment: experience in the Ministry of Health of Brazil].
    Silva MT
    Rev Peru Med Exp Salud Publica; 2011; 28(3):548-51. PubMed ID: 22086639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Care to compare?
    Aston G
    Hosp Health Netw; 2008 Dec; 82(12):38-41, 1. PubMed ID: 19209502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 9. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

  • 11. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

  • 12. Health technology assessment (HTA) increasingly important in spine research.
    van Tulder M
    Eur Spine J; 2011 Jul; 20(7):999-1000. PubMed ID: 21720729
    [No Abstract]   [Full Text] [Related]  

  • 13. Written in the stars. Introducing our five-star rating system.
    Health Devices; 2010 Mar; 39(3):73. PubMed ID: 21309267
    [No Abstract]   [Full Text] [Related]  

  • 14. Health technology assessment: the contribution of qualitative research.
    Leys M
    Int J Technol Assess Health Care; 2003; 19(2):317-29. PubMed ID: 12862189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 17. Health technology assessment and primary data collection for reducing uncertainty in decision making.
    Goeree R; Levin L; Chandra K; Bowen JM; Blackhouse G; Tarride JE; Burke N; Bischof M; Xie F; O'Reilly D
    J Am Coll Radiol; 2009 May; 6(5):332-42. PubMed ID: 19394574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis.
    Kaltenthaler E; Carroll C; Hill-McManus D; Scope A; Holmes M; Rice S; Rose M; Tappenden P; Woolacott N
    Health Technol Assess; 2016 Apr; 20(26):1-48. PubMed ID: 27049841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosimilars: evidential standards for health technology assessment.
    Hughes DA
    Clin Pharmacol Ther; 2010 Mar; 87(3):257-61. PubMed ID: 20160743
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid response in health technology assessment: a Delphi study for a Brazilian guideline.
    Silva MT; Silva END; Barreto JOM
    BMC Med Res Methodol; 2018 Jun; 18(1):51. PubMed ID: 29884121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.